Skip to main content

and
  1. Article

    Open Access

    PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19

    The ongoing COVID-19 pandemic has claimed more than 6 million lives and continues to test the world economy and healthcare systems. To combat this pandemic, the biological research community has shifted effort...

    James Logue, Arup R. Chakraborty, Robert Johnson, Girija Goyal in Communications Biology (2022)

  2. Article

    Open Access

    mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

    The SARS-CoV-2 Omicron variant evades vaccine-induced immunity. While a booster dose of ancestral mRNA vaccines effectively elicits neutralizing antibodies against variants, its efficacy against Omicron in old...

    Etsuro Nanishi, Marisa E. McGrath, Timothy R. O’Meara in Communications Biology (2022)

  3. Article

    Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

    Understanding the molecular basis for immune recognition of SARS-CoV-2 spike glycoprotein antigenic sites will inform the development of improved therapeutics. We determined the structures of two human monoclo...

    **hui Dong, Seth J. Zost, Allison J. Greaney, Tyler N. Starr in Nature Microbiology (2021)